1.31 USD
↗ 0.02 (1.55%)AT CLOSE (03:59 PM EDT)
RenovoRx, Inc. Common Stock
RNXTNASDAQ • USD
1.29
↘ 0.02 (1.53%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
1.29
↘ 0.02 (1.53%)
Market: CLOSED
RenovoRx, Inc. Common Stock (RNXT) is currently trading at $1.30. Technicals currently rate "Buy" while our fundamental analysis reads "Neutral". Notable factors include a robust Altman Z-Score, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Oct 26, 2026.
Open?$1.30
High?$1.34
Low?$1.27
Prev. Close?$1.29
Volume?182.3K
Avg. Volume?516.6K
VWAP?$1.31
Rel. Volume?0.35x
Bid / Ask
Bid?$1.26 × 1.0K
Ask?$1.31 × 200
Spread?$0.05
Midpoint?$1.29
Valuation & Ratios
Market Cap?59.1M
Shares Out?45.1M
Float?43.3M
Float %?96.2%
P/E Ratio?N/A
P/B Ratio?6.58
EPS?-$0.27
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site (known as intra-arterial, or IA delivery) to bathe the target tumor, while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
Employees
17
Market Cap
58.2M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2021-08-26
Address
2570 W. EL CAMINO REAL, STE. 320,
MOUNTAIN VIEW, CA 94040
Phone: 408-800-2649
MOUNTAIN VIEW, CA 94040
Phone: 408-800-2649
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?76
Momentum?50
Short Sent.?69
Piotroski F-Score?3/9Weak
Altman Z-Score?3.16Safe
Confidence?57%Low
Short InterestLow
Short % of Float?2.00%Low
Short Interest?864.6K
Days to Cover?1.6
Free Float43.3M
Avg Daily Volume528.3K
Settlement Date2026-10-15
Financial Health
Current Ratio?5.74Strong
Quick Ratio?5.53Strong
Cash Ratio?5.03Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score58/100
P/E?N/A▾
P/B?6.58FAIR▾
Peers100
S&P28
P/S?29.92HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-3.7CHEAP▾
S&P97
EV/Sales?25.12HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-136.8%WEAK▾
S&P3
ROA?-107.1%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-11937000
Enterprise Value?$49.6M
Fundamentals ratios updated end of day